Yonezawa Hamari’s High Potency Drug Substance Manufacture Plant
Yonezawa Hamari has a dedicated high potency drug substance manufacture facility built in March 2019. The facility manages substances with OEL 1 to 10 μg/m3, Category 4 (Pharma Solutions Co., Ltd.’s Classification) and suitable for injection grade APIs. The Hamari Group is expanding its manufacture capabilities to cover highly potent drug substances and provide a comprehensive production system.